MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-30-2022
Genetic Technologies Limited Cash Conversion Cycle 2011-2026 | GENE
Annual Cash Conversion Cycle Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 11 K | 1.18 | 61.8 | 169 | 48 | -47.6 | -41.1 | 46.1 | -187 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 K | -187 | 1.23 K |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 19.5 | 8.76 % | $ 210 M |  China |
 |
Agilent Technologies
A
|
111 | $ 121.0 | 2.98 % | $ 36.8 B |  USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.49 | 3.92 % | $ 932 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 516.32 | 3.01 % | $ 14.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.85 | 5.77 % | $ 449 M | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 8.28 | 3.44 % | $ 1.06 B | USA |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 1.44 | -1.03 % | $ 1.92 M | USA |
 |
Natera
NTRA
|
81.5 | $ 213.25 | 5.62 % | $ 21 B | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 29.14 | 2.07 % | $ 20 B |  Niderland |
 |
Castle Biosciences
CSTL
|
45.9 | $ 24.43 | 3.82 % | $ 679 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Senseonics Holdings
SENS
|
36.1 | $ 6.76 | 0.53 % | $ 282 M | USA |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.62 | -0.04 % | $ 2.67 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 180.06 | 0.96 % | $ 8.92 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
77.5 | $ 198.18 | 1.18 % | $ 141 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 526.87 | 2.46 % | $ 199 B | USA |
 |
Illumina
ILMN
|
142 | $ 129.95 | 2.35 % | $ 20.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 56.8 | 12.74 % | $ 3.4 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 15.73 | 2.81 % | $ 476 M | USA |
 |
Guardant Health
GH
|
79.6 | $ 85.3 | 3.76 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.85 | - | $ 92.5 K | USA |
 |
Biomerica
BMRA
|
172 | $ 2.1 | 0.96 % | $ 4.82 M | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 112.98 | 2.36 % | $ 9.32 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 267.53 | 1.27 % | $ 22.3 B | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.55 | 4.43 % | $ 2.07 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 82.57 | 1.1 % | $ 5.57 B | USA |
 |
Waters Corporation
WAT
|
731 | $ 330.99 | 1.94 % | $ 19.7 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 193.93 | 0.53 % | $ 21.5 B | USA |